statistiche ricercatore

statistiche per PETTA, Salvatore

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2236
EU - Europa 764
AS - Asia 498
SA - Sud America 39
AF - Africa 37
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2192
IT - Italia 335
CN - Cina 268
DE - Germania 121
GB - Regno Unito 95
CA - Canada 37
IN - India 37
TR - Turchia 29
ES - Italia 27
FR - Francia 27
IE - Irlanda 26
AU - Australia 25
KR - Corea 22
JP - Giappone 21
BD - Bangladesh 19
BR - Brasile 18
GR - Grecia 17
SE - Svezia 15
ZA - Sudafrica 15
EG - Egitto 14
NL - Olanda 14
VN - Vietnam 14
IR - Iran 13
BE - Belgio 11
IL - Israele 11
PL - Polonia 11
TW - Taiwan 11
ID - Indonesia 10
RO - Romania 10
NO - Norvegia 9
PK - Pakistan 9
UA - Ucraina 9
RU - Federazione Russa 8
CL - Cile 7
PH - Filippine 7
DK - Danimarca 6
CH - Svizzera 5
CO - Colombia 5
HK - Hong Kong 5
MX - Messico 5
MY - Malesia 5
SA - Arabia Saudita 5
AT - Austria 4
PE - Perù 4
TH - Thailandia 4
AR - Argentina 3
BG - Bulgaria 3
HU - Ungheria 3
IQ - Iraq 3
BF - Burkina Faso 2
CU - Cuba 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
NG - Nigeria 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
FI - Finlandia 1
GE - Georgia 1
GN - Guinea 1
HR - Croazia 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
NZ - Nuova Zelanda 1
SG - Singapore 1
Totale 3601
Salva come PNG Salva come JPEG
Città #
Fairfield 385
Woodbridge 237
Seattle 181
Ashburn 180
Houston 180
Buffalo 166
Palermo 150
Cambridge 131
Wilmington 117
Ann Arbor 112
Beijing 56
Shanghai 38
Wuhan 28
Menlo Park 25
Mountain View 25
Nanjing 21
Las Vegas 20
University Park 20
Izmir 19
Phoenix 19
Aliso Viejo 16
Guangzhou 13
Muizenberg 12
Riva 12
Birkenhead 11
Chengdu 11
Los Angeles 11
Clearwater 10
Hanoi 10
Rochester 10
Xian 10
Ottawa 9
Oxford 9
San Francisco 9
Changsha 8
Hangzhou 8
Dallas 7
Dhaka 7
Duncan 7
New York 7
Simi Valley 7
Taipei 7
Toronto 7
Bad Vilbel 6
Carlsbad 6
Dearborn 6
Henderson 6
Mainz 6
Oslo 6
Pietra Ligure 6
Saint Louis 6
Seoul 6
Sydney 6
Ube 6
Washington 6
Austin 5
Avetrana 5
Bologna 5
Brisbane 5
Easton 5
Guangdong 5
Islamabad 5
Jinan 5
Nürnberg 5
Rome 5
Antwerpen 4
Bangalore 4
Chennai 4
Chicago 4
Favara 4
Fuzhou 4
Gent 4
Hamilton 4
Indianapolis 4
Istanbul 4
Jacksonville 4
Madrid 4
Medellín 4
Milan 4
Pisa 4
Pittsburgh 4
Rasht 4
San Antonio 4
Southsea 4
Atlanta 3
Berlin 3
Birmingham 3
Buenos Aires 3
Central District 3
College Station 3
Corpus Christi 3
Croix 3
Downers Grove 3
Edinburgh 3
Farmington 3
Genzano Di Roma 3
Göteborg 3
Hefei 3
Konya 3
Lincoln 3
Totale 2574
Salva come PNG Salva come JPEG
Nome #
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial, file 799043 592
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease., file 130254 361
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C, file 130233 248
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection., file 130235 164
TM6SF2gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease, file 131594 155
A "systems medicine" approach to the study of non-alcoholic fatty liver disease, file 253460 144
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease, file 135412 125
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women, file 256327 120
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C, file 418565 111
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS, file 465485 104
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, file 253473 97
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C., file 337584 87
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study., file 526121 87
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis, file 253634 86
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis, file 253481 84
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, file 104672 81
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis., file 104151 80
Antidiabetic drugs in NAFLD: The accomplishment of two goals at once?, file 673497 80
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease, file 673485 74
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease, file 675808 69
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance, file 74178 69
Genetic background in nonalcoholic fatty liver disease: A comprehensive review, file 253614 67
Iperuricemia: significato clinico e nuove prospettive di trattamento, file 138509 55
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity, file 570141 55
Reply to: Is industrial fructose just a marker of an unhealthy dietary pattern?, file 104898 45
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients., file 133964 42
Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients"., file 72077 42
Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation, file 679559 37
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV, file 468315 33
Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives, file 799007 33
The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives, file 799015 32
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease, file 799051 32
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease, file 316263 26
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS, file 571061 19
Hepatitis C virus and cardiovascular: A review, file 467934 17
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals, file 466636 15
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, file 466645 15
Pathophysiology of non alcoholic fatty liver disease, file 466657 15
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS, file 145011 13
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort, file 689143 8
Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression: An observational study in patients with nonalcoholic fatty liver disease, file 466661 7
Reply, file 47281 7
FibroScan Detects Cardiovascular Damage in Patients With NAFLD, file 673493 6
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network, file 466533 4
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals, file 467614 4
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients, file 799055 4
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model, file 316153 3
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study, file 586333 3
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis, file 673529 3
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis, file 73118 3
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation, file 798995 3
Metabolic Factors and Chronic Hepatitis C: A Complex Interplay, file 104772 2
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease, file 104797 2
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C., file 135416 2
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C, file 256319 2
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection, file 348473 2
Coffee and tea breaks for liver health, file 467927 2
Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature, file 468155 2
Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: spectators or actors?, file 47221 2
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C., file 601540 2
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population, file 639286 2
The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance, file 689135 2
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease, file 72013 2
How to optimize HCV therapy in genotype 1 patients: predictors of response., file 72053 2
Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis, file 799030 2
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease, file 799034 2
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients, file 847405 2
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease, file 104670 1
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection, file 104752 1
Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients?, file 104795 1
Update on treatment strategies in patients with non-alcoholic fatty liver disease, file 104892 1
Reply to: “Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients”, file 104894 1
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C., file 135379 1
Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients., file 135413 1
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C, file 135584 1
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage, file 256311 1
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease, file 256315 1
Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients., file 339721 1
Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis., file 342395 1
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease, file 349383 1
The cheating liver: imaging of focal steatosis and fatty sparing, file 411064 1
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C, file 434067 1
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C, file 43558 1
Evidence-Based Medicine and the Problem of Healthy Volunteers, file 466521 1
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study, file 466641 1
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C, file 466673 1
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT, file 466682 1
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT, file 466788 1
Liver follicular helper T-cells in chronic hepatitis C, file 467210 1
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel, file 467747 1
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease, file 467938 1
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study, file 467954 1
Can we prevent and modify cardiometabolic disorders by controlling HCV infection?, file 468170 1
Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection., file 47225 1
Hyperuricemia in non-alcoholic fatty liver disease: authors' reply., file 47389 1
Is liver stiffness measurement unreliable in obese patients? authors' reply., file 47393 1
Is global elimination of HCV realistic?, file 545981 1
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver, file 545985 1
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents, file 591834 1
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030, file 673509 1
Totale 3731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3762
article - articoli 3638
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7400
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2015/201691 00914 143 1010 81175
2016/2017131 613619 1011 710 913207
2017/2018210 13111011 1414 1556 29121312
2018/2019684 18192731 2218 1624 5797187168
2019/20202022 14086112216 149176 156180 231168207201
2020/2021543 1722271440 00 00 0000
Totale 3762
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2020